Bridgeway Capital Management’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding OPTN
NCM
MP
SCM
ACA
KCM
BL
RA
Bridgeway Capital Management's OPTN Position: Q1 2025 in Review
Bridgeway Capital Management sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 15,713 shares — an estimated $105K sold.
Bridgeway Capital Management first reported a position in OPTN in Q1 2021 and held it in 16 quarters. The position peaked at $1.17M in Q1 2021. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.
- Bridgeway Capital Management reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
- Bridgeway Capital Management sold 15,713 OptiNose shares in Q1 2025, an estimated $105K.
- Bridgeway Capital Management first reported a position in OptiNose in Q1 2021 and held it in 16 quarters.
- Bridgeway Capital Management's OptiNose position peaked at $1.17M in Q1 2021.
- 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.
Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.